Effect of Androgen Suppression on Clinical Outcomes in Hospitalized Men With COVID-19-Reference-Cited by-同舟云学术

Effect of Androgen Suppression on Clinical Outcomes in Hospitalized Men With COVID-19

Published:2022-04-19 Issue:4 Volume:5 Page:e227852
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Nickols Nicholas G.¹²³,Mi Zhibao⁴,DeMatt Ellen⁴,Biswas Kousick⁴,Clise Christina E.⁵,Huggins John T.⁶⁷,Maraka Spyridoula⁸⁹,Ambrogini Elena⁸⁹,Mirsaeidi Mehdi S.¹⁰,Levin Ellis R.¹¹¹²,Becker Daniel J.¹³¹⁴,Makarov Danil V.¹⁵¹⁶,Adorno Febles Victor¹⁵¹⁶,Belligund Pooja M.¹⁷,Al-Ajam Mohammad¹⁷,Muthiah Muthiah P.¹⁸¹⁹,Montgomery Robert B.²⁰²¹,Robinson Kyle W.²²²³,Wong Yu-Ning²²²³,Bedimo Roger J.²⁴²⁵,Villareal Reina C.²⁶,Aguayo Samuel M.²⁷,Schoen Martin W.²⁸²⁹,Goetz Matthew B.³⁰³¹,Graber Christopher J.³⁰,Bhattacharya Debika³⁰,Soo Hoo Guy³²,Orshansky Greg³¹³³,Norman Leslie E.⁴,Tran Samantha³⁴,Ghayouri Leila³⁴,Tsai Sonny³⁴,Geelhoed Michelle³⁴,Rettig Mathew B.³⁴³⁵

Affiliation:

1. Radiation Oncology Service, VA Greater Los Angeles Healthcare System, Los Angeles, California

2. Department of Radiation Oncology, University of California, Los Angeles

3. Department of Urology, University of California, Los Angeles

4. VA Cooperative Studies Program Coordinating Center, Perry Point, Maryland

5. VA Cooperative Studies Program Clinical Research Pharmacy Coordinating Center, Albuquerque, New Mexico

6. Pulmonary and Critical Care Medicine, Ralph H. Johnson VA Medical Center, Charleston, South Carolina

7. Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Medical University of South Carolina, Charleston

8. Medicine Service, Central Arkansas Veterans Healthcare System, Little Rock

9. Division of Endocrinology and Metabolism, University of Arkansas for Medical Sciences, Little Rock

10. Division of Pulmonary, Critical Care and Sleep, College of Medicine–Jacksonville, University of Florida, Jacksonville

11. Division of Endocrinology, Long Beach VA Medical Center, Long Beach, California

12. Division of Endocrinology, Department of Medicine, University of California, Irvine

13. Division of Hematology and Oncology VA New York Harbor Healthcare System, Manhattan Campus, New York

14. Perlmutter Cancer Center, NYU Langone Medical Center, New York, New York

15. VA New York Harbor Healthcare System, Manhattan Campus, New York

16. NYU Grossman School of Medicine, New York, New York

17. VA New York Harbor Healthcare System, Brooklyn Campus, Brooklyn

18. Veterans Affairs Medical Center, Memphis, Tennessee

19. University of Tennessee Health Science Center, Memphis

20. Division of Hematology and Oncology, VA Puget Sound Health Care System, Seattle, Washington

21. Division of Medical Oncology, Department of Medicine, University of Washington, Seattle

22. Department of Hematology and Oncology, Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania

23. Division of Hematology-Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia

24. VA North Texas Health Care System, Dallas

25. UT Southwestern Medical Center, School of Medicine, Dallas, Texas

26. Michael E. DeBakey VA Medical Center, Houston, Texas

27. Pulmonary and Critical Care Medicine, Phoenix VA Health Care System, Phoenix, Arizona

28. John Cochran Veterans Affairs Medical Center, St Louis, Missouri

29. Department of Medicine, Saint Louis University School of Medicine, St Louis, Missouri

30. Infectious Diseases Section, VA Greater Los Angeles Healthcare System, Los Angeles, California

31. Department of Medicine, University of California, Los Angeles

32. Pulmonary, Critical Care and Sleep Section, VA Greater Los Angeles Healthcare System, Los Angeles, California

33. Clinical Informatics, VA Greater Los Angeles Healthcare System, Los Angeles, California

34. Division of Hematology-Oncology, Department of Medicine, VA Greater Los Angeles Healthcare System, Los Angeles, California

35. Departments of Medicine and Urology, University of California, Los Angeles

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2791293/nickols_2022_oi_220246_1649859914.21644.pdf

Reference25 articles.

1. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor.;Hoffmann;Cell,2020

2. Androgen receptor structure, function and biology: from bench to bedside.;Davey;Clin Biochem Rev,2016

3. Targeting androgen regulation of TMPRSS2 and ACE2 as a therapeutic strategy to combat COVID-19.;Deng;iScience,2021

4. Targeting transcriptional regulation of SARS-CoV-2 entry factors ACE2 and TMPRSS2.;Qiao;Proc Natl Acad Sci U S A,2020

5. Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532).;Montopoli;Ann Oncol,2020

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sex hormones in COVID‐19 severity: The quest for evidence and influence mechanisms;Journal of Cellular and Molecular Medicine;2024-06

2. Factores genéticos asociados a long COVID;Medicina de Familia. SEMERGEN;2024-03

3. Antiandrogens as Therapies for COVID-19: A Systematic Review;Cancers;2024-01-10

4. Physicochemical Characteristics of Antimicrobials and Practical Recommendations for Intravenous Administration: A Systematic Review;Antibiotics;2023-08-19

5. Men, testosterone and Covid‐19;Clinical Endocrinology;2023-07-27